Propofol microdroplet formulations
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jun 10, 1997
Grant Date -
N/A
app pub date -
Mar 19, 1996
filing date -
Mar 19, 1996
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Formulations of phospholipid-coated microdroplets of propofol devoid of fats and triglycerides provide chronic sedation over extended periods of time without fat overload. Being free of nutrients that support bacterial growth, these microdroplet formulations are bacteriosatic and bactericidal (e.g. self-sterilizing) and thus have extended shelf life.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully